Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab.

@article{Bruera2012EffectivenessOL,
  title={Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab.},
  author={Gemma Bruera and Katia Cannita and Felice Giuliante and Paola Lanfiuti Baldi and Roberto Vicentini and Paolo Marchetti and Gennaro Nuzzo and Adelmo Antonucci and Corrado Ficorella and Enrico Ricevuto},
  journal={Clinical colorectal cancer},
  year={2012},
  volume={11 2},
  pages={119-26}
}
BACKGROUND Intensive medical treatment increases resection rate of liver metastases in patients with metastatic colorectal cancer (MCRC). The effectiveness of liver metastasectomies was evaluated in patients with MCRC who were treated with previously reported FIr-B/FOx (triplet chemotherapy plus bevacizumab). PATIENTS AND METHODS Fifty patients with MCRC enrolled in the reported phase II study were classified according to involved metastatic sites (liver-only metastatic site, multiple… CONTINUE READING
11 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…